Navigation Links
Pfenex Announces Strategic Collaboration With MedImmune for the Use of Pfenex Expression Technology™
Date:5/10/2011

SAN DIEGO, May 10, 2011 /PRNewswire/ -- Pfenex Inc., an industry leader in protein expression through the Pfenex Expression Technology™ platform, announced today a three year strategic collaboration with MedImmune LLC, the global biologics business of AstraZeneca. The agreement provides MedImmune with non-exclusive access to Pfenex Expression Technology and scientific resources for the development of bioprocesses for human therapeutic proteins and vaccines.

Pfenex Inc. will engineer production strains and develop early production processes for MedImmune's proprietary molecules. A Joint Steering Committee will be established to oversee the collaboration and facilitate the decision-making process. This collaboration provides MedImmune with access to an industry-leading expression platform and process development team that will enable preclinical and clinical development for these molecules to progress quickly and efficiently. MedImmune will provide annual technology access fees, FTE resource funding and will also have pre-agreed commercial license terms.

"This partnership with MedImmune will facilitate speed and reliability in the development of protein therapeutics and vaccines to serve unmet medical needs," said Dr. Bertrand Liang, CEO of Pfenex Inc. "Integrating our efforts early will allow for the rapid progression of early stage candidate molecules through discovery and development."

"We are very excited to initiate this collaboration with Pfenex" said Dr. Gail Wasserman, Senior Vice President of Biopharmaceutical Development at MedImmune. "Their scientific approach to strain development and protein expression is robust and aligned with the way we work at MedImmune.  Working collaboratively with Pfenex by harnessing their novel platform will play an important role in helping accelerate some of our early pipeline programs."

About Pfenex Inc.

Pfenex Inc. is a protein production company leveraging the unique and powerful Pfenex Expression Technology™ platform based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals.  For more information please visit www.pfenex.com

About MedImmune, LLC

MedImmune, the global biologics unit for AstraZeneca PLC (LSE: AZN.L, NYSE: AZN), has approximately 3,500 employees worldwide and is headquartered in Gaithersburg, Maryland. For more information, visit MedImmune's website at www.medimmune.com.


'/>"/>
SOURCE Pfenex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™
2. Pfenex Inc. Establishes Reagent Protein Distribution Agreement With Cedarlane Corporation
3. Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthr
4. Pfenex Grants Exclusive License to Merck & Co., Inc. for the Production of Proteins for Undisclosed Vaccine Program
5. Insmed Announces First Quarter 2011 Financial Results
6. Intercell AG Announces Q1 2011 Results and Updates on R&D Progress
7. Mindray Announces First Quarter 2011 Financial Results
8. Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China
9. Rosetta Genomics Announces Issuance of Additional U.S. Patent
10. Frantz Medical Group Announces the Promotion of Stephanie Harrington to Chief Operating Officer
11. Avanir Pharmaceuticals Announces Appointment of Elona Kogan, Esq. as Vice President of Legal Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Feb. 9, 2016  Bluestar Silicones will promote its ... for long-term implant applications and announce certification of ... Manufacturing (MD&M) West Conference (Booth #1759), February 9-10, ... --> --> Available in 01 ... offer outstanding physical properties enabling our customers to ...
(Date:2/8/2016)... -- Alzheimer Diagnostic Tests - Medical Devices Pipeline ... sector report , "Alzheimer Diagnostic Tests - Medical ... Alzheimer Diagnostic Tests currently in pipeline stage. ... products with comparative analysis of the products at ... players involved in the pipeline product development. It ...
(Date:2/8/2016)... Feb.8, 2016 Aesthetic Devices - Medical Devices ... sector report, "Aesthetic Devices - Medical Devices Pipeline Assessment, ... pipeline stage. This report is prepared ... research by GlobalData,s team of industry experts. *Note: ... altered based on the availability and relevance of data ...
Breaking Medicine Technology:
(Date:2/9/2016)... York, NY (PRWEB) , ... February 09, 2016 , ... ... the appointment of Dr. David Hung to the company´s Board of Directors. ... a world class scientist and an exceptional entrepreneur.” said Juan Jose Chacon Quiros, CEO ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, ... Younkers department stores, announced it has raised $176,000 to benefit the Breast Cancer ... Cancer Center at the University of Iowa, The Lynn Sage Cancer Research Foundation, ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... will ensure lab personnel have a basic understanding of the techniques they use ... Enhanced understanding will help them reduce waste and rework to create a leaner ...
(Date:2/9/2016)... ... , ... United Methodist Communications collaborated with Chocolate Moose Media ... video designed to prevent the next widespread Ebola outbreak from occurring in ... throughout Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire and other African countries, with ...
(Date:2/9/2016)... ... ... Shark Finds and Kevin Harrington, and the Product Managers of AsSeenOnTV.pro are pleased ... newly patented product that has solved some of the basic problems golfers have faced since ... or right after a rain shower, might understand the struggle of placing the club down ...
Breaking Medicine News(10 mins):